Raw Materials Disinfecting, autoclaving and discarding of waste material Cleaning of glassware, vessels and other small equipment/ material Chemical dispensary.

Slides:



Advertisements
Similar presentations
Page 1 Private & Confidential NextPharma Technologies Holding Limited Sterile Product Development Centre (SPDC) At Braine-lAlleud, Belgium.
Advertisements

Montpellier - FRANCE. Who are we ? 100% private, family-owned company 48 employees All our products are completely manufactured in our laboratories ISO.
Producing a Pharmaceutical or Biopharmaceutical
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
FACT SHEET o Established in the Year 2010 and excise benefit upto o The production unit is a large scale in size. o The company has established.
Dr. Mohsen SHATERZADEH Ambassador of the I.R.IRAN Brasilia, March. 2, 2011 Presented to the Mr. Robson Braga, President of CNI.
1 Empowering Business in Real Time. © Copyright 2009, OSIsoft Inc. All rights Reserved. Providing a Single Point for Accessing and Reporting Historical.
Since 1903 the VSVRI has been established on an area of about 23 square hectares in the Red Mountain area of the Abbassia district, east Cairo. The.
Threats and constraints | Onderstepoort Biological Products © |22nd February 2013Page 31 Negative perception – OBP Brand (RVF) Product availability-equipment.
Bio-manufacturing Overview
Latin (Scientific) Adjectives
Quality and Consistency of Cell Culture Media with a Highlight on FMDV
What is the autoclave thing again. Sanitization: fancy word for Cleaning Removing of foreign material Dirt, body fluids, lubricants Using detergents,
ERT 211 BIOCHEMICAL ENGINEERING. Course Outcome  Ability to describe the usage and methods for cultivating plant and animal cell culture.
Water Conservation in SMEs through Small and medium enterprise.
Number of unit : 3 Course type : Core Prerequisite: None.
MARKET SIZE 2012 | Onderstepoort Biological Products © |22nd February 2013Page 21 Estimated market size Estimated total market share ( OBP) Estimated vaccine.
Introduction to Lab 6: Ex. Preparation of Culture Media
Importance of vaccines. | Onderstepoort Biological Products © |22nd February 2013Page 15.
 A central concept is that quality cannot be tested for! ◦ Testing programs are based on testing a statistically significant number of samples  However.
Progress Report – Week 9 Section AC, Group 2 Presented by Andrew Amodei Teammates: David Bergsman, Michael Huang, Elizabeth Lam May 24 th, 2012.
Tissue Culture (Cell Culture) Toxicology Testing In Vitro
Module 3 | Slide 1 0f Sanitation and Hygiene Basic Principles of GMP Section 3.
What Limits the Rate of Vaccine Development and Production? Alan R. Shaw VaxInnate Corporation.
Microbial Biotechnology Commercial Production of Microorganism
Wastewater Treatment Processes
Cultivation To propagate the viral particle in its specific host i.e. Increase viral concentration through support viral replication.
Unit 17: Vaccination & Immunization.  Vaccination Mechanical act of administering a vaccine for the purpose of developing immunity in an animal Amount.
TARU HAAPANIEMI DG AGRI, E.II.4 EUROPEAN COMMISSION Instrument for Pre-accession Assistance - Rural Development
FERMENTATION.
Good Practices in Production and Quality Control Related Guidelines
ONDERSTEPOORT BIOLOGICAL PRODUCTS LTD PRESENTATION TO THE PORTFOLIO COMMITTEE 1 JULY 2009.
Module 3Slide 1 of 26 WHO - EDM Sanitation and Hygiene Basic Principles of GMP.
THE BIOTECHNOLOGY WORKPLACE. OVERVIEW Biotechnology workplaces Laboratories.
Plant flexibility Market factors – Flexibility to produce alternative products – Produce multiple products simultaneously Societal trends – Utilization.
Lab safety rules practical NO (1) Dalia Kamal Eldien Mohammed.
What do we need GMP compliant facility (R1 billion 2008) Flow, segregation, containment, environmental, statutory Modern technologies for raw material,
Module 2 Inactivated poliovirus vaccine (IPV) attributes and storage requirements Training for Inactivated Poliovirus Vaccine (IPV) introduction.
FINANCIAL POSITION | Onderstepoort Biological Products © |22nd February 2013Page 73.
Module 3Slide 1 of 26 WHO - EDM Sanitation and Hygiene Basic Principles of GMP.
| Onderstepoort Biological Products © | November 22, 2010.
| Onderstepoort Biological Products © |22nd February 2013Page 58 √ OBP √ 2008.
| Onderstepoort Biological Products © |22nd February 2013Page 63 Regulatory Compliance Revolution.
Fermentation Fermentation is the term used by microbiologists to describe any process for the production of a product by means of the mass culture of a.
Cell culture based vaccine production : Engineering Bottlenecks Etienne Malhaize, Director of Technical Service – Process Biotech. NAE/IOMConference April.
Working safely with Biological materials Aseptic technique, sterilization and tissue culture techniques.
Chapter 6: Plant and Animal Cell Bioreactors
National 5 Biology Course Notes Unit 1 : Cell Biology Part 3 : Producing new cells.
In the name of God. Common Technical Document On Biotech.
Animal Health Status in Jordan All Animal Diseases are obligatory notifiable and controlled under MOA law and regulation. All Animal Diseases are obligatory.
Batch and Continuous Flow
Latin Adjectives.
TOPIC OUTLINE Methods of cultivating animal cells
Workforce Profile Occupational Levels Male Female Total A C I W
PHARMACEUTICAL PROCESS ENGINEERING
FOOD & NUTRACEUTICAL UNIT
Author: Nurul Azyyati Sabri
SANITATION & HYGIENE KHADIJAH ADE-ABOLADE MPH. FPCPharm.
Producing a Pharmaceutical or Biopharmaceutical
(Gaurav Gupta, Vaccine Technology Centre, Zydus Cadila, India)
INDUSTRIAL PERSPECTIVES FOR VL VACCINE DEVELOPMENT: DEVELOPING COUNTRY
Laboratory facilities
A Look at Livestock Terminology
Basis Operations in Industrial Fermentations
Producing a Pharmaceutical or Biopharmaceutical
GMP: Good manufacutring practices
Producing a Pharmaceutical or Biopharmaceutical
Possible Solutions | Onderstepoort Biological Products © |22nd February 2013.
Pre-GMP Facility at ANA FUTURA Preliminary advanced equipment
Infection Control Practices
Presentation transcript:

Raw Materials Disinfecting, autoclaving and discarding of waste material Cleaning of glassware, vessels and other small equipment/ material Chemical dispensary Small medium production Bulk medium production (bacterial vaccines) Viral medium production (viral vaccines) Ice-packs Key Challenges Recycling of glassware – cleaning validation challenge therefore need to move to disposable/single-use options Recycling of plasticware e.g. roller bottles – is a no, no for GMP Hand washing as opposed to washing machines to do the work – capital investment into new equipment needed | Onderstepoort Biological Products © |22nd February 2013Page 53 Washing Glassware Dispensary Viral medium Autoclaving/ Sterilization

Bacterial Vaccine Production 28 bacterial vaccines – batch production 6 diagnostic reagents Inactivated vaccines Live vaccines Multivalent products Combination products 2, 5, 10, 20, 50 and 100 and 500 dose pack sizes Bovine (cattle), Ovine (sheep), Caprine (goat), Avian (poultry), Equine, (horses) Fermentors – aerobic and anaerobic Key Challenges Full plant needs to be upgraded - new equipment and increased capacity, needed as current equipment is becoming redundant and difficult to maintain and not supported by original manufacturer, proper process and people flow, new or upgraded facility to accommodate new equipment (proper ventilation, access etc) No pilot plant facility and equipment | Onderstepoort Biological Products © |22nd February 2013Page 54 Pilot fermentor Production fermentors Pilot fermentor

| Onderstepoort Biological Products © |22nd February 2013Page 55

Viral Vaccine Production 13 viral vaccines - batch production Inactivated vaccines Live vaccines Multivalent products Combination product 1, 5, 20, 50, 100 and 500 dose pack sizes Bovine (cattle), Ovine (sheep), Caprine (goat), Avian (poultry), Equine (horses) Roller bottles – different primary and continuous cell lines Embryonated eggs Mostly open production system Key Challenges Open production processes, monolayers Lack of HVAC Older technology (roller bottles, bottles of medium – new biobags and bioreactors (suspension cells) Sharing of formulation room No pilot plant facility and equipment | Onderstepoort Biological Products © |22nd February 2013Page 56 Egg inoculation Closed system Open system Roller bottles

| Onderstepoort Biological Products © |22nd February 2013Page 57 Viral vaccine manufacturing – then and now….